Data Cart

Your data extract

0 variables
0 samples
View Cart
ATPRIVDRUG (V784M)
Place for HIV test: Private pharmacy, drug store, or dispensary
Return to HIV/AIDS testing, general variables list

Codes and Frequencies



Can't find the category you are looking for? Try the Detailed codes

Description

ATPRIVDRUG (V784M) indicates whether, in response to an open-ended question, the woman reported a private pharmacy, drug store, or dispensary as a source for testing for the AIDS virus.

Some samples in the "AT" series include categories that can be consolidated into a single response. IPUMS-DHS uses supplemental programming to combine these responses in a standard variable while preserving the separate responses in country-specific variables.

For example, a given sample might include multiple categories for different types of private drug sources that could be combined in ATPRIVDRUG to create a more comprehensive response category. See Comparability for more information on the specific categories combined in this variable.

Comparability — Index

GENERAL
Benin
Burundi
 Chad
Ghana
Mali
 Nigeria
Rwanda
Tanzania

Comparability

Apart from universe differences and slight variation in response category wording, ATPRIVDRUG is largely comparable across samples. Most commonly, samples categorized this response under a "private medical sector" header and labeled it "pharmacy." Some samples combined "pharmacy" with other drug sources, such as "chemist" or "drug store," into a single response.

In other cases, samples separate "pharmacy" and other private, formal drug sources into distinct categories. As ATPRIVDRUG focuses on all private, formal drug sources, IPUMS-DHS consolidates these response categories in this variable to form a single, comprehensive response. Countries of particular interest are noted below.

Due to the variation in category wording, IPUMS-DHS users are encouraged to review the Survey Text tab.

Most commonly, this variable included women who have heard of HIV/AIDS and have never been tested for HIV/AIDS. Other samples diverge from this standard, and in these cases, researchers may wish to exclude women who have not heard of HIV/AIDS (using AIDSHEARD) and who have been tested for HIV/AIDS (using AIDTESTEV).

Comparability - Standard DHS

ATPRIVDRUG (V784M) is included in Phase V of the Standard DHS questionnaire. Although this response category is removed from the standard questionnaire for Phase VI, some Phase VI samples still included ATPRIVDRUG.

Comparability — Benin [top]

In the 2011 Benin survey, under the "Private Medical Sector" header, there are two separate categories for "pharmacy" and "university dispensary." As ATPRIVDRUG focuses on all private, formal drug sources, these two responses are consolidated in this variable to create a more comprehensive response category. For researchers interested in preserving these country-specific categories:

  • Pharmacy is listed as ATBJ12 in IPUMS-DHS
  • University dispensary is listed as ATBJ13 in IPUMS-DHS

Comparability — Burundi [top]

In the 2016 Burundi survey, under the "Private Medical Sector" header, there are two separate categories for "pharmacy" and "university dispensary." As ATPRIVDRUG focuses on all private, formal drug sources, these two responses are consolidated in this variable to create a more comprehensive response category. For researchers interested in preserving these country-specific categories:

  • University dispensary is listed as ATBI7 in IPUMS-DHS
  • Pharmacy is listed as ATBI8 in IPUMS-DHS

Comparability — Chad [top]

The 2004 and 2014 Chad surveys include "Pharmacy/pharmaceutical depot" as a response category.

Comparability — Ghana [top]

In the 2008 and 2014 Ghana surveys, under the "Private Medical Sector" header, there are two separate categories for "pharmacy" and "chemical/drug store." As ATPRIVDRUG focuses on all private, formal drug sources, these two responses are consolidated in this variable to create a more comprehensive response category. For researchers interested in preserving these country-specific categories:

  • Chemical/drug store is listed as ATGH1 in IPUMS-DHS
  • Pharmacy is listed as ATGH2 in IPUMS-DHS

Comparability — Mali [top]

In the 2012 Mali survey, under the "Private Medical Sector" header, there are two separate categories for "pharmacy" and "university dispensary." As ATPRIVDRUG focuses on all private, formal drug sources, these two responses are consolidated in this variable to create a more comprehensive response category. For researchers interested in preserving these country-specific categories:

  • Pharmacy is listed as ATML11 in IPUMS-DHS
  • University dispensary is listed as ATML12 in IPUMS-DHS

Comparability — Nigeria [top]

In the 2008 Nigeria survey, under the "Private Medical Sector" header, there are two separate categories for "pharmacy" and "chemist/PMS [Patent Medicine Store]." As ATPRIVDRUG focuses on all private, formal drug sources, these two responses are consolidated in this variable to create a more comprehensive response category. For researchers interested in preserving these country-specific categories:

  • Chemist/PMS is listed as ATNG1 in IPUMS-DHS
  • Pharmacy is listed as ATNG2 in IPUMS-DHS

Comparability — Rwanda [top]

In the 2010, 2014 and 2019 Rwanda surveys, under the "Private Medical Sector" header, there are two separate categories for "dispensary" and "pharmacy." As ATPRIVDRUG focuses on all private, formal drug sources, these two responses are consolidated in this variable to create a more comprehensive response category. For researchers interested in preserving these country-specific categories:

  • Dispensary is listed as ATRW8 in IPUMS-DHS
  • Pharmacy is listed as ATRW9 in IPUMS-DHS

Comparability — Tanzania [top]

In the 2010 Tanzania survey, under the "Private Medical Sector" header, there are two separate categories for "pharmacy" and "dispensary." As ATPRIVDRUG focuses on all private, formal drug sources, these two responses are consolidated in this variable to create a more comprehensive response category. For researchers interested in preserving these country-specific categories:

  • Pharmacy is listed as ATTZ5 in IPUMS-DHS
  • Dispensary is listed as ATTZ6 in IPUMS-DHS

Universe

  • Afghanistan 2015: Ever-married women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Angola 2015: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Benin 2001: All women age 15-49.
  • Benin 2006: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Benin 2011: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Benin 2017: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS, in households selected for the men's survey.
  • Burkina Faso 2010: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Burundi 2010: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Burundi 2016: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Cameroon 2011: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS, in households selected for the men's survey.
  • Cameroon 2018: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Chad 2004: Women age 15-49 who have heard of HIV/AIDS, have never been tested for HIV/AIDS, and who know of a place to be tested.
  • Chad 2014: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS, in households selected for the men's survey.
  • Cote d'Ivoire 1994: Women age 15-49 who have heard of HIV/AIDS.
  • Cote d'Ivoire 2011: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Egypt 2005: Ever-married women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Egypt 2014: Ever-married women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Ghana 2008: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Ghana 2014: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Guinea 2012: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Guinea 2018: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • India 2015: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS, in households selected for the state module.
  • Lesotho 2009: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Lesotho 2014: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Liberia 2007: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Liberia 2013: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Madagascar 2003: Women age 15-49 who have heard of HIV/AIDS and know of a place to get tested for HIV/AIDS.
  • Madagascar 2008: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS, in households selected for the men's survey.
  • Mali 2012: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Myanmar 2015: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Namibia 2006: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Namibia 2013: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Nepal 2016: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Niger 2012: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Nigeria 2008: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Nigeria 2013: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Pakistan 2017: Ever-married women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Rwanda 2000: Women age 15-49 who have heard of HIV/AIDS and know of a place to get an HIV/AIDS test.
  • Rwanda 2010: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Rwanda 2014: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Senegal 2005: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Senegal 2010: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Senegal 2014: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Senegal 2015: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Senegal 2016: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Senegal 2017: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • South Africa 2016: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Tanzania 1996: Women age 15-49 who have heard of HIV/AIDS.
  • Tanzania 2010: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Togo 2013: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Uganda 1995: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Uganda 2006: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Uganda 2011: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Uganda 2016: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Zambia 2018: Women age 15-49 who have heard of HIV/AIDS and have never been tested for HIV/AIDS.
  • Afghanistan: 2015-C, 2015-W, 2015-B, 2015-W
  • Angola: 2015-W, 2015-C, 2015-B, 2015-W
  • Benin: 2001-W, 2001-C, 2001-B, 2006-W, 2006-B, 2006-C, 2006-W, 2011-B, 2011-C, 2011-W, 2017-W, 2017-C, 2017-B, 2017-W
  • Burkina Faso: 2010-W, 2010-B, 2010-C, 2010-W
  • Burundi: 2010-W, 2010-C, 2010-B, 2010-W, 2016-W, 2016-C, 2016-B
  • Cameroon: 2011-C, 2011-B, 2011-W, 2018-W, 2018-C, 2018-B
  • Chad: 2004-W, 2004-C, 2004-B, 2014-W, 2014-C, 2014-B
  • Cote d'Ivoire: 1994-W, 1994-C, 1994-B, 2011-W, 2011-C, 2011-B
  • Egypt: 2005-B, 2005-W, 2005-W, 2005-C, 2014-B, 2014-C, 2014-W, 2014-W
  • Ghana: 2008-B, 2008-W, 2008-C, 2014-B, 2014-C, 2014-W
  • Guinea: 2012-B, 2012-C, 2012-W, 2018-W, 2018-C, 2018-B, 2018-W
  • India: 2015-W, 2015-C, 2015-B, 2015-W
  • Lesotho: 2009-W, 2009-C, 2009-B, 2009-W, 2014-W, 2014-B, 2014-C, 2014-W
  • Liberia: 2007-W, 2007-C, 2007-B, 2013-W, 2013-C, 2013-B, 2013-W
  • Madagascar: 2003-B, 2003-W, 2003-C, 2003-W, 2008-B, 2008-C, 2008-W, 2008-W
  • Mali: 2012-W, 2012-C, 2012-B
  • Myanmar: 2015-C, 2015-W, 2015-B, 2015-W
  • Namibia: 2006-B, 2006-W, 2006-C, 2006-W, 2013-B, 2013-C, 2013-W, 2013-W
  • Nepal: 2016-W, 2016-B, 2016-C, 2016-W
  • Niger: 2012-W, 2012-B, 2012-C, 2012-W
  • Nigeria: 2008-B, 2008-C, 2008-W, 2013-B, 2013-C, 2013-W, 2013-W
  • Pakistan: 2017-W, 2017-C, 2017-B, 2017-W
  • Rwanda: 2000-W, 2000-W, 2000-C, 2000-B, 2010-B, 2010-C, 2010-W, 2014-B, 2014-W, 2014-C
  • Senegal: 2005-C, 2005-W, 2005-B, 2005-W, 2010-W, 2010-W, 2010-B, 2010-C, 2014-B, 2014-W, 2014-C, 2014-W, 2015-W, 2015-B, 2015-W, 2015-C, 2016-B, 2016-C, 2016-W, 2016-W, 2017-W, 2017-C, 2017-B, 2017-W
  • South Africa: 2016-W, 2016-C, 2016-B, 2016-W
  • Tanzania: 1996-W, 1996-B, 1996-C, 2010-B, 2010-C, 2010-W
  • Togo: 2013-W, 2013-C, 2013-B
  • Uganda: 1995-W, 1995-C, 1995-B, 2006-B, 2006-C, 2006-W, 2006-W, 2011-W, 2011-C, 2011-W, 2011-B, 2016-W, 2016-C, 2016-B, 2016-W
  • Zambia: 2018-W, 2018-C, 2018-B, 2018-W